CONMED crushed expectations with a 24% EPS beat as portfolio optimization and international growth offset a planned exit from gastroenterology. The company raised full-year guidance to $4.48 to $4.60 per share, now expecting 5% to 6% organic constant currency sales growth.
ConMed :
CNMD
CNMD
Stock Data
$51.25
$1.99 (4.04%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL DEVICES
Conmed Corp is a global medical technology company specializing in the development, manufacture, and sale of surgical devices and related equipment. It offers a wide range of products for orthopedic surgery, including innovative solutions for soft tissue injuries and minimally invasive sports medicine surgeries. Conmed also provides advanced tools for general surgery, such as insufflation systems, smoke removal devices, and electrosurgical solutions. Additionally, it offers endoscopic technologies for gastroenterology procedures and various products for patient monitoring. Founded in 1970, Conmed is committed to supporting healthcare professionals in hospitals and surgery centers around the world.
Latest Activity
All ConMed Articles
0 Articles
No articles found for ConMed.